{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:27Z","timestamp":1792723107334,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurot.2026.e01079","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:33:44Z","timestamp":1789724024000},"page":"e01079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A brief acceptance and commitment therapy intervention for individuals at risk of neurodegenerative disease: A translational study in inherited prion disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Rhianna","family":"Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Dindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Pauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01079_bib1","article-title":"The psychological experience of living at risk of an autosomal dominant neurological condition: a scoping review","author":"Brien","year":"2026","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurot.2026.e01079_bib2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.neurot.2026.e01079_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1474-4422(25)00451-X","article-title":"Genetic causes and modifiers of prion diseases","volume":"25","author":"Mead","year":"2026","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2026.e01079_bib4","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.gim.2022.06.003","article-title":"Genetic counselling for prion disease: updates and best practices","volume":"24","author":"Goldman","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.neurot.2026.e01079_bib5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41431-022-01132-8","article-title":"Estimation of the number of inherited prion disease mutation carriers in the UK","volume":"30","author":"Corbie","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurot.2026.e01079_bib6","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A systematic review of prion therapeutics in experimental models","volume":"129","author":"Trevitt","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e01079_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ejhg.2014.42","article-title":"Predictive testing for inherited prion disease: report of 22 years' experience","volume":"22","author":"Owen","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurot.2026.e01079_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fgene.2019.00895","article-title":"Genetic testing in prion disease: psychological consequences of the decisions to know or not to know","volume":"10","author":"Schwartz","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.neurot.2026.e01079_bib9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3390\/jpm12081222","article-title":"Using a clinical formulation to understand psychological distress in people affected by huntington's disease: a descriptive, evidence-based model","volume":"12","author":"Dale","year":"2022","journal-title":"J Personalized Med"},{"key":"10.1016\/j.neurot.2026.e01079_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12687-022-00624-w","article-title":"Identification of psychoeducation needs and an intervention response for pre-symptomatic huntington's disease","volume":"14","author":"Gluyas","year":"2023","journal-title":"J Community Genet"},{"key":"10.1016\/j.neurot.2026.e01079_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JHD-200418","article-title":"Psychological interventions for people with huntington's disease: a call to arms","volume":"9","author":"Zarotti","year":"2020","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.neurot.2026.e01079_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/BrImp.2019.2","article-title":"Third-wave therapies for long-term neurological conditions: a systematic review to evaluate the status and quality of evidence","volume":"20","author":"Robinson","year":"2019","journal-title":"Brain Impair"},{"key":"10.1016\/j.neurot.2026.e01079_bib13","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/S0140-6736(24)00533-6","article-title":"Acceptance and commitment therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK","volume":"403","author":"Gould","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neurot.2026.e01079_bib14","series-title":"Acceptance and Commitment Therapy: the Process and Practice of Mindful Change","author":"Hayes","year":"2011"},{"key":"10.1016\/j.neurot.2026.e01079_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cpr.2016.04.009","article-title":"A systematic review of the use of acceptance and commitment therapy (ACT) in chronic disease and long-term conditions","volume":"46","author":"Graham","year":"2016","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.neurot.2026.e01079_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jcbs.2023.08.004","article-title":"The impact of acceptance and commitment therapy (ACT) on quality of life and symptom improvement among chronic health conditions: a systematic review and meta-analysis","volume":"29","author":"Konstantinou","year":"2023","journal-title":"J Context Behav Sci"},{"key":"10.1016\/j.neurot.2026.e01079_bib17","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.1097\/NNR.0000000000000499","article-title":"Systematic review and meta-analysis of effectiveness of acceptance and commitment therapy in patients with breast cancer","volume":"70","author":"Li","year":"2021","journal-title":"Nurs Res"},{"key":"10.1016\/j.neurot.2026.e01079_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/18796397251315162","article-title":"Acceptance and commitment therapy with huntington's disease: a narrative review and case report of a caregiver-assisted intervention","volume":"14","author":"Schriger","year":"2025","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.neurot.2026.e01079_bib19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/papt.12321","article-title":"Psychological interventions for people with parkinson's disease in the early 2020s: where do we stand?","volume":"94","author":"Zarotti","year":"2021","journal-title":"Psychol Psychother"},{"key":"10.1016\/j.neurot.2026.e01079_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/bjhp.12475","article-title":"Therapists' perceptions of barriers and facilitators to uptake and engagement with therapy in long-term conditions","volume":"26","author":"Carroll","year":"2021","journal-title":"Br J Health Psychol"},{"key":"10.1016\/j.neurot.2026.e01079_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/17437199.2022.2073901","article-title":"Experiences of psychological interventions in neurodegenerative diseases: a systematic review and thematic synthesis","volume":"17","author":"Pinto","year":"2023","journal-title":"Health Psychol Rev"},{"key":"10.1016\/j.neurot.2026.e01079_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcbs.2021.03.003","article-title":"Single-session acceptance and commitment therapy (ACT) interventions for patients with chronic health conditions: a systematic review and meta-analysis","volume":"20","author":"Dochat","year":"2021","journal-title":"J Context Behav Sci"},{"key":"10.1016\/j.neurot.2026.e01079_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.copsyc.2015.01.018","article-title":"One-day acceptance and commitment training workshops in medical populations","volume":"2","author":"Dindo","year":"2015","journal-title":"Curr Opin Psychol"},{"key":"10.1016\/j.neurot.2026.e01079_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12160-009-9083-x","article-title":"Teaching acceptance and mindfulness to improve the lives of the obese: a preliminary test of a theoretical model","volume":"37","author":"Lillis","year":"2009","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.neurot.2026.e01079_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7224\/1537-2073-12.4.200","article-title":"A novel application of acceptance and commitment therapy for psychosocial problems associated with multiple sclerosis","volume":"12","author":"Sheppard","year":"2010","journal-title":"Int J MS Care"},{"key":"10.1016\/j.neurot.2026.e01079_bib26","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1080\/09602011.2025.2457666","article-title":"\u201cIt's knowing that there are other people and they've accepted it\u201d: patients' experiences of an acceptance and commitment therapy group intervention for people with neurological conditions","volume":"35","author":"Storey","year":"2025","journal-title":"Neuropsychol Rehabil"},{"key":"10.1016\/j.neurot.2026.e01079_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s13311-017-0521-3","article-title":"Acceptance and commitment therapy: a transdiagnostic behavioral intervention for mental health and medical conditions","volume":"14","author":"Dindo","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2026.e01079_bib28","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"Br Med J"},{"key":"10.1016\/j.neurot.2026.e01079_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"Br Med J"},{"key":"10.1016\/j.neurot.2026.e01079_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.neurot.2026.e01079_bib31","series-title":"Innovations in acceptance and commitment therapy: clinical Advances and Applications in ACT","first-page":"203","article-title":"One-day ACT workshops for patients with chronic health problems and associated emotional disorders","author":"Dindo","year":"2020"},{"key":"10.1016\/j.neurot.2026.e01079_bib32","series-title":"The ACT Matrix: a New Approach to Building Psychological Flexibility Across Settings and Populations","year":"2014"},{"key":"10.1016\/j.neurot.2026.e01079_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101178","article-title":"Feasibility of delivering a virtual 1-day acceptance and commitment therapy workshop to rural veterans through community partnerships","volume":"34","author":"Dindo","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.neurot.2026.e01079_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12913-022-07577-3","article-title":"Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions","volume":"22","author":"Sekhon","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.neurot.2026.e01079_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40814-023-01291-5","article-title":"Recommendations for progression criteria during external randomised pilot trial design, conduct, analysis and reporting","volume":"9","author":"Mellor","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.neurot.2026.e01079_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40814-020-00634-w","article-title":"Guidance for conducting feasibility and pilot studies for implementation trials","volume":"6","author":"Pearson","year":"2020","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.neurot.2026.e01079_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.neurot.2026.e01079_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","article-title":"The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories","volume":"33","author":"Lovibond","year":"1995","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.neurot.2026.e01079_bib39","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s11136-019-02177-x","article-title":"Systematic review of the measurement properties of the depression anxiety stress Scales-21 by applying updated COSMIN methodology","volume":"28","author":"Lee","year":"2019","journal-title":"Qual Life Res"},{"key":"10.1016\/j.neurot.2026.e01079_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcbs.2020.08.007","article-title":"A psychometric comparison of psychological inflexibility measures: discriminant validity and item performance","volume":"18","author":"Ong","year":"2020","journal-title":"J Context Behav Sci"},{"key":"10.1016\/j.neurot.2026.e01079_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcbs.2016.05.003","article-title":"The development and validation of the comprehensive assessment of acceptance and commitment therapy processes (CompACT)","volume":"5","author":"Francis","year":"2016","journal-title":"J Context Behav Sci"},{"key":"10.1016\/j.neurot.2026.e01079_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The world health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.neurot.2026.e01079_bib43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the world health organization WHOQOL-BREF quality of life assessment","volume":"28","year":"1998","journal-title":"Psychol Med"},{"key":"10.1016\/j.neurot.2026.e01079_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jad.2024.06.115","article-title":"Variability in treatment effects in an English national dataset of psychological therapies: the relationships between severity, treatment duration, and therapy type","volume":"362","author":"Saxon","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neurot.2026.e01079_bib45","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036525","article-title":"Predictive genetic counseling for neurodegenerative diseases: past, present, and future","volume":"10","author":"Goldman","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neurot.2026.e01079_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1742395313516133","article-title":"Identifying gaps in knowledge: a map of the qualitative literature concerning life with a neurological condition","volume":"10","author":"Audulv","year":"2014","journal-title":"Chron Illness"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:55:56Z","timestamp":1792720556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1878747926002497"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01079","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief acceptance and commitment therapy intervention for individuals at risk of neurodegenerative disease: A translational study in inherited prion disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01079"}}